Medscape July 29, 2021
Roxanne Nelson, RN, BSN

A remote monitoring system was highly effective in managing symptoms and improving quality of life among patients with cancer who were receiving chemotherapy, say researchers reporting the first clinical trial of the new approach.

The study tested the Advanced Symptom Management System (ASyMS) for patients with various cancer types who were undergoing treatment at cancer centers in several European countries. The study primarily focused on patients who were being treated with curative intent.

The 24-hour monitoring system optimized symptom management in a manner safe, secure, and in “real time,” the team reports. This is particularly relevant during the COVID-19 pandemic, they note.

“Our findings suggest that an evidence based remote monitoring intervention, such as ASyMS, has potential for implementation into...

Today's Sponsors

Transcarent
SalesSparx
Canton & Company

Today's Sponsors

Oscar
Curation Health

Today's Sponsor

TripleTree

 
Topics: Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Telehealth, Trends, Wearables
Brightline Goes Nationwide, Will Offer Virtual Behavioral Health Support For Kids, Teens, and Families
Does Telemedicine for Diagnosis Have a Place in Healthcare?
Caresyntax Raises Additional $30M for Digital Surgery Platform
Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A Unicorn
The Pros and Cons of Biometrics in Healthcare